e-learning
resources
Munich 2014
Monday, 08.09.2014
Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is it necessary to give tuberculosis treatment daily throughout?
K. C. Chang, C. C. Leung, S. S. Huang, C. M. Tam (Hong Kong, Hong Kong)
Source:
International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Session:
Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Session type:
Thematic Poster Session
Number:
2614
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. C. Chang, C. C. Leung, S. S. Huang, C. M. Tam (Hong Kong, Hong Kong). Is it necessary to give tuberculosis treatment daily throughout?. Eur Respir J 2014; 44: Suppl. 58, 2614
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
Home based tuberculosis (TB) care program
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Liver injury in treatment of latent tuberculosis infection - is the age cut-off for treatment justified?
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014
Features of pulmonary tuberculosis in migrants
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Is there a need for prolonged follow up in mono-drug resistant TB?
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Detection of tuberculosis in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
The particularities of new cases of tuberculosis at homeless people
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Tuberculosis (TB) and depression
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Perinatal tuberculosis: A forgotten disease?
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016
Spreading of tuberculosis with extensive drug resistant MBTin Northwest region of Russia
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Immunodiagnosis of tuberculosis infection in children under the age of five - Which testing is feasible?
Source: International Congress 2015 – Paediatric bronchology
Year: 2015
Cholecalciferol supplementation in patients taking anti tuberculosis treatment
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Lymphocytopenia in pulmonary tuberculosis: Does it have a clinical value?
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Experience of using diaskintest in adult patients with tuberculosis and non-tuberculosis respiratory diseases in a regional TB hospital
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Modern social and clinical characteristics of miliary tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Statin use and the risk of tuberculosis: Data from 305,142 patients
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016
The feature of BCG complications in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Risk factors for disseminated tuberculosis
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Properties of cultures of
M. tuberculosis
isolated from the surfaces of objects TB facilities
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Chloroquine as a potential adjunctive therapy in tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept